TD Cowen Maintains Buy on Natera, Raises Price Target to $137

TD Cowen analyst Dan Brennan maintains Natera (NASDAQ:NTRA) with a Buy and raises the price target from $123 to $137.

Benzinga01:35

CRISPR Therapeutics Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/10/2024 85.26% Oppenheimer $102 → $95 Maintains Outperform 05/09/2024 67.71% JMP Securities → $86 Reite

Benzinga00:46

Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Diodes Incorporated (NASDAQ:DIOD) fell sharply during Friday's session after the company reported worse-than-expected quarterly financial results.Diodes posted adjusted earnings of 28 cents

Benzinga00:44

Novavax Hits a 52-week High as Sanofi Deal Prompts J.P. Morgan Upgrade

Seeking AlphaMay 10 23:15

Genpact Posts Upbeat Earnings, Joins Groupon, Natera, Funko, CarGurus And Other Big Stocks Moving Higher On Friday

U.S. stocks were mostly higher, with the Dow Jones gaining over 100 points on Friday.

BenzingaMay 10 22:48

Arrowhead Pharmaceuticals Shares Are Trading Lower After the Company Reported Q2 Financial Results.

Arrowhead Pharmaceuticals Shares Are Trading Lower After the Company Reported Q2 Financial Results.

BenzingaMay 10 22:22